Gene · 5244
Papers3,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differences in Exposure to Minimally Invasive Surgery in a Sample of United States Obstetrics and Gynecology Residents. | Cureus | 2023 | 37791220 | PubTator, text mining | PubMed |
| Fibroblast growth factors induce hepatic tumorigenesis post radiofrequency ablation. | Sci Rep | 2023 | 37770545 | PubTator, text mining | PubMed |
| Featuring molecular regulation of bile acid homeostasis in pediatric short bowel syndrome. | Clin Res Hepatol Gastroenterol | 2023 | 37769812 | PubTator, text mining | PubMed |
| Management and outcomes after liver transplantation for progressive familial intrahepatic cholestasis: A systematic review and meta-analysis. | Hepatol Commun | 2023 | 37756114 | PubTator, text mining | PubMed |
| ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitis. | Hum Genomics | 2023 | 37735492 | PubTator, text mining | PubMed |
| Outcomes of 38 patients with PFIC3: Impact of genotype and of response to ursodeoxycholic acid therapy. | JHEP Rep | 2023 | 37701337 | PubTator, text mining | PubMed |
| The Mutational Landscape Of Genetic Cholestatic Diseases In Pakistani Children. | J Pak Med Assoc | 2023 | 37697751 | PubTator, text mining | PubMed |
| Type IV P-Type ATPases: Recent Updates in Cancer Development, Progression, and Treatment. | Cancers (Basel) | 2023 | 37686603 | PubTator, text mining | PubMed |
| Changes in Expression and Function of Placental and Intestinal P-gp and BCRP Transporters during Pregnancy. | Int J Mol Sci | 2023 | 37685897 | PubTator, text mining | PubMed |
| Generation and characterization of a zebrafish knockout model of abcb4, a homolog of the human multidrug efflux transporter P-glycoprotein. | Hum Genomics | 2023 | 37674192 | PubTator, text mining | PubMed |
| Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives. | Mol Ther Oncolytics | 2023 | 37663132 | PubTator, text mining | PubMed |
| Identification of cancer stemness and M2 macrophage-associated biomarkers in lung adenocarcinoma. | Heliyon | 2023 | 37662825 | PubTator, text mining | PubMed |
| Natural polymers as potential P-glycoprotein inhibitors: Pre-ADMET profile and computational analysis as a proof of concept to fight multidrug resistance in cancer. | Heliyon | 2023 | 37662819 | PubTator, text mining | PubMed |
| Primary sclerosing cholangitis and the path to translation. | J Clin Invest | 2023 | 37655665 | PubTator, text mining | PubMed |
| Ancistrocladinium A Induces Apoptosis in Proteasome Inhibitor-Resistant Multiple Myeloma Cells: A Promising Therapeutic Agent Candidate. | Pharmaceuticals (Basel) | 2023 | 37631095 | PubTator, text mining | PubMed |
| An Overview of the Enhanced Effects of Curcumin and Chemotherapeutic Agents in Combined Cancer Treatments. | Int J Mol Sci | 2023 | 37628772 | PubTator, text mining | PubMed |
| The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma. | Cells | 2023 | 37626893 | PubTator, text mining | PubMed |
| Molecular surveillance of Plasmodium falciparum drug-resistance markers in Vietnam using multiplex amplicon sequencing (2000-2016). | Sci Rep | 2023 | 37626131 | PubTator, text mining | PubMed |
| Recent Advances in Curcumin-Based Combination Nanomedicines for Cancer Therapy. | J Funct Biomater | 2023 | 37623653 | PubTator, text mining | PubMed |
| Human Placental Mesenchymal Stem Cells Relieve Primary Sclerosing Cholangitis via Upregulation of TGR5 in Mdr2-/- Mice and Human Intrahepatic Cholangiocyte Organoid Models. | Research (Wash D C) | 2023 | 37600495 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5244/papers?page=12